Our Top Five Biotech Takeout Picks
Health-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.
Karen Anderson: I'm Karen Anderson, senior biotechnology analyst at Morningstar. With me today to discuss the 2010 mergers and acquisitions environment in biotech is our biotech analyst, Lauren Migliore. Thanks for joining us, Lauren.
Lauren Migliore: Good to be here, Karen.
Karen Andersen does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.